BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Otologic

Claire Quang
September 20, 2018 3:17 PM UTC

Mouse studies suggest inhibiting DDIT3 or PERK could help treat hearing loss. In a mouse model of genetic hearing loss, systemic knockout of DDIT3 decreased hearing loss compared with normal DDIT3 exp...

BCIQ Company Profiles

University of California San Francisco

BCIQ Target Profiles

DNA-damage-inducible transcript 3 (DDIT3) (CHOP10) (CHOP) (GADD153)

Eukaryotic translation initiation factor 2 (eIF2) alpha kinase 3 (PERK) (EIF2AK3)

BCIQ Company Profiles

University of California San Francisco

BCIQ Target Profiles

DNA-damage-inducible transcript 3 (DDIT3) (CHOP10) (CHOP) (GADD153)

Eukaryotic translation initiation factor 2 (eIF2) alpha kinase 3 (PERK) (EIF2AK3)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS